Products for Research Use Only
RegisterLogin

R-1479

CAT: 0804-HY-10444-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10444-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
R-1479 (4'-Azidocytidine), a nucleoside analogue, is a specific inhibitor of RNA-dependent RNA polymerase (RdRp) of HCV. R-1479 inhibits HCV replication in the HCV subgenomic replicon system (IC50=1.28 μM) [1][2][3]. R-1479 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
CAS Number
478182-28-4
Product Name Alternative
4'-Azidocytidine
UNSPSC
12352005
Target
DNA/RNA Synthesis; HCV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/R-1479.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC[C@]1(N=[N+]=[N-])[C@@H](O)[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O1
Molecular Formula
C9H12N6O5
Molecular Weight
284.23
References & Citations
[1]Klumpp K, et al. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem. 2006 Feb 17;281 (7) :3793-9.|[2]Smith DB, et al. Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479. Bioorg Med Chem Lett. 2007 May 1;17 (9) :2570-6.|[3]Nguyen NM, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 2013 May 1;207 (9) :1442-1450.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-W998245(R, R, R) -AHPC (hydrochloride)
HY-W018061C-01(R, R) -Traxoprodil
HY-103451(R, R) -THC
HY-128888-01(R, R) -GSK321
HY-113834(R, R) -Ethambutol
HY-100443B-01(R, R) -PX20606
HY-B0761(R, R) -Glycopyrrolate
HY-59125-01(R, R) - (+) -Hydrobenzoin
HY-100741C-01(R, R) -S63845
HY-153321A-01(R, R) -Bexobrutideg

Alternative Products

CatalogName
BA1864-5.1R-1479
A11540-1R-1479 1mg
A11540-100R-1479 100mg
A11540-50R-1479 50mg
A11540-10R-1479 10mg
A11540-5R-1479 5mg
A11540-25R-1479 25mg
A11540-2R-1479 2mg
A11540-10mM-DR-1479 10mM * 1mL in DMSO
555635SCR-1479

Popular Products